BIODESIX INC — Director's Dealing 2020

Oct 28, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: Georgantas Robert William III (SVP, Rsrch & Trans'l Science)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy)	$0.78	2030-12-31	Common Stock (33693)		Direct
Stock Option (Right to buy)	$0.78	2030-04-14	Common Stock (29481)		Direct

Footnotes

F1: This option vests 40% on August 5, 2021, and the remaining 60% in 36 successive, equal monthly installments measured from August 5, 2021.

F2: This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021.